🔎 Trials Near Me

Hjem › Plateepitelcancer i hode og hals › Pennsylvania › Philadelphia

Kliniske studier for Plateepitelcancer i hode og hals i Philadelphia, PA

26 studier for Plateepitelcancer i hode og hals søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

RekruttererFase 3
  • Thomas Jefferson University Hospital, Philadelphia
  • Jefferson Torresdale Hospital, Philadelphia
  • Asplundh Cancer Pavilion, Willow Grove · 13 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06992427

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RekruttererFase 1
  • Exelixis Clinical Site #98, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

RekruttererFase 3
  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07276399

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

RekruttererFase 2
  • Thomas Jefferson University Hospital, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

RekruttererFase 3
  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
Alder 60 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04892173

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

RekruttererFase 1
  • University of Pennsylvania, Philadelphia
Alder 18 til 74 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07219212

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

RekruttererFase 2
  • Thomas Jefferson University Hospital, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
  • Jefferson Torresdale Hospital, Philadelphia
Alder 18 til 79 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04671667

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RekruttererObservasjonsstudie
  • University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

RekruttererFase 2
  • Fox Chase Cancer Center, Philadelphia
  • Temple University Hospital, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT02734537

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

RekruttererFase 2
  • Research Site, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06535607

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

RekruttererObservasjonsstudie
  • University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06163534

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

RekruttererFase 1
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07216105

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

RekruttererFase 2
  • Asplundh Cancer Pavilion, Willow Grove · 13 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06769698

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RekruttererFase 1
  • Normunity Investigational Site, Philadelphia
  • Normunity Investigational Site, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

RekruttererFase 2/3
  • Thomas Jefferson University Hospital, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04333537

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

RekruttererFase 3
  • Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi unna
  • Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07441681

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

RekruttererFase 1/2
  • University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT03526835

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

RekruttererFase 1
  • Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT04777994

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

RekruttererFase 3
  • GSK Investigational Site, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 26. mai 2026 · NCT06256588

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

RekruttererFase 1
  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 12. mai 2026 · NCT06747390

Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

RekruttererFase 1
  • Fox Chase Cancer Center, Philadelphia
  • Temple University Hospital, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 15. apr. 2026 · NCT07455032

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

RekruttererFase 3
  • Fox Chase Cancer Center, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06064877

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT07030257

Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality

Rekrutterer
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT05031910

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

RekruttererFase 1
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06778863

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

RekruttererFase 3
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 15. okt. 2025 · NCT06699212

Plateepitelcancer i hode og hals-studier i andre byer

Andre studier i Philadelphia

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.